Lieberman David
Division of Gastroenterology, Portland VA Medical Center, Portland, Ore 97239, USA.
Am J Med. 2006 Sep;119(9):728-35. doi: 10.1016/j.amjmed.2006.03.037.
Screening average-risk populations for colorectal cancer can reduce the incidence and mortality of colorectal cancer. Effectiveness depends on programmatic adherence and quality. This review discusses the evidence supporting the use of currently available screening tests. The discussion specifically focuses on programmatic issues and highlights the importance of quality assurance in each program.
对平均风险人群进行结直肠癌筛查可降低结直肠癌的发病率和死亡率。其有效性取决于方案的依从性和质量。本综述讨论了支持使用现有筛查测试的证据。讨论特别关注方案问题,并强调每个方案中质量保证的重要性。